Strategies in pain management: New and potential indications for COX-2 specific inhibitors

Journal of Pain and Symptom Management

Volumn 25, Issue 2 SUPPL., 2003, Pages 21-31

  Ruoff, Gary ^a,d   Lema, Mark ^b,c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d Westside Family Medical Center   (United States)

Author keywords

Acute pain; Cancer pain; Coxibs; Dysmenorrhea; Nociception; NSAIDs; Opioids; Perioperative analgesia

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; ROFECOXIB;

CANCER PAIN; CLINICAL TRIAL; CONSTIPATION; DYSMENORRHEA; GASTROINTESTINAL DISEASE; GENERAL ANESTHESIA; HUMAN; ILEUS; LOW BACK PAIN; NAUSEA; PAIN; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; TOOTH EXTRACTION; TOOTH PAIN; TREATMENT INDICATION;

EID: 0037322970     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0885-3924(02)00628-0     Document Type: Review

References (41)

1. Caudill MA, Holman GH, Turk D. Effective ways to manage chronic pain. Patient Care 1996:154-172.
2. Katz W.A. Approach to the management of nonmalignant pain. Am J Med. 101(suppl 1A):1996;54S-63S.
3. Gurwitz J.H., Avorn J., Bonn R.L.et al. Initiation of antihypertensive treatment during nonsteroidal anti- inflammatory drug therapy. JAMA. 272:1994;781-786.
4. Kendall B.J., Peura D.A. NSAID-associated gastrointestinal damage and the elderly. Practical Gastroenterology. 17:1993;13-29.
5. Bombardier C. An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol. 89(6A):2002;3D-9D.
6. Coco A.S. Primary dysmenorrhea (Review). Am Fam Phys. 60(2):1999;489-496.
7. Deligeorogiou E. Dysmenorrhea (Review). Annual NY Acad Sci. 900:2000;237-244.
8. Harlow S.D., Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol. 103:1996;1134-1142.
9. Jamieson D.J., Steege J.F. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol. 87(1):1996;55.
10. Chan W.Y., Dawood M.Y. Prostaglanding levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Adv Prostaglandin Thromboxane Res. 8:1980;1443-1447.
11. Zhang W.Y., Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhoea. a systematic review Br J Obs Gynaecol. 105:1998;780-789.
12. Morrison B.W., Daniels S.E., Kotey P.et al. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea. a randomized controlled trial Obstet Gynecol. 94(4):1999;504-508.
13. Kaplan B., Peled Y., Pardo J.et al. Transcutaneous electrical nerve stimulation (TENS) as a relief of dysmenorrhoea. Clin Exp Obstet Gynecol. 21:1994;87-90.
14. The Transdermal Nitroglycerine/Dysmenorrhea Study Group Transdermal nitroglycerine in the management of pain associated with primary dysmenorrhea. a multinational pilot study J Int Med Res. 25:1997;41-44.
15. Harel Z., Bhiro F.M., Kottenhahn R.K.et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. 174:1996;1335-1338.
16. Lichten E.M., Bombard J. Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation. J Reproductive Med. 32:1987;37-41.
17. Dionne R.A., Gordon S.M. Nonsteroidal anti-inflammatory drugs for acute pain control (Review). Dent Clin North Am. 38(4):1994;645-667.
18. Ahmad N., Grad H.A., Haas D.A.et al. The efficacy of nonopioid analgesics for postoperative dental pain. a meta-analysis Anesth Prog. 44(4):1997;119-126.
19. Moore P.A. Pain management in dental practice. tramadol vs. codeine combinations J Am Dent Assoc. 130:1999;1075-1179.
20. Morrison B.W., Christensen S., Yuan W.et al. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain. a randomized, controlled trial Clin Ther. 21(6):1999;943-953.
21. Geis G.S. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor. what can we expect? J Rheumatol. 26(Suppl. 56):1999;31-36.
22. Malmstrom K., Daniels S., Kotey P.et al. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain. a randomized, placebo and active comparator-controlled clinical trial Clin Ther. 21(10):1999;1653-1663.
23. Frymoyer J.W., Cats-Baril W.L. An overview of the incidences and costs of low back pain. Orthop Clin North Am. 22(2):1991;263-271.
24. Zagari M.J., Mazonson P.D., Longton W.C. Pharmacoeconomics of chronic nonmalignant pain. PharmacoEconomics. 10(4):1996;356-377.
25. Webster B.S., Snook S.H. The cost of 1989 workers' compensation low back pain claims. Spine. 19(10):1994;1111-1115.
26. Katz N., Johnson K.E., Krupa D.A.et al. Rofecoxib in the treatment of chronic low back pain in two multicenter trials. J Pain. 2(Part 2):2001;718. abs.
27. Perkins F.M., Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 93:2000;1123-1133.
28. Mannion R.J., Woolf C.J. Pain mechanisms and management. a central perspective Clin J Pain. 16(3 Suppl):2000;5144-5156.
29. deLeon-Casasola O.A., Parker B.M., Lema M.J., Groth R.I., Orsini-Fuentes J. Epidural analgesia versus intravenous patient-controlled analgesia. Reg Anesth. 19:1994;307-315.
30. Kelly D.J., Ahmad M., Brull S.J. Preemptive analgesia II. recent advances and current trends Can J Anaesth. 48:2001;1091-1101.
31. Woolf C.R., Chong M.S. Preemptive analgesia - treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 77:1993;362-379.
32. Kehlet H., Mogensen T. Hospital stay of 2 days after open sigmoidectomy with a multimodal rehabilitation programme. Br J Surg. 86:1999;227-230.
33. Reuben S.S., Bhopatkar S., Maciolek H., Joshi W., Sklar J. The preemptive analgesic effect of refecoxib after ambulatory arthroscopic knee surgery. Anesth Analg. 94:2002;55-59.
34. Senturk M., Ozcan P.E., Talu G.K.et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 94:2002;11-45.
35. Chang H.M. Cancer pain management. Med Clin North Am. 83:1999;711-736.
36. McDonnell F.J., Sloan J.W., Hamann S.R. Advances in cancer pain management. Curr Pain Headache Rep. 5:2001;265-271.
37. Cherny N.I., Portenoy R.K. Practical issues in the management of cancer pain. Wall P.D., Melzack R. Textbook of Pain. 4th Edition:1999;1479-1522 Churchchill Livingston, New York.
38. Cherny N.I. The management of cancer pain. CA-Ca J Clin. 50:2000;70-116.
39. Olson K.B., Pienta K.J. Pain management in patients with advanced prostate cancer. Oncology (Huntington). 13:1999;1537-1550.
40. Jenkins C.A., Bruera E. Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients. Palliat Med. 13:1999;183-196.
41. Mercadante S. The use of anti-inflammatory drugs in cancer pain. Cancer Treat Rev. 27:2001;51-61.